Data / Form D filings / Glenveigh Pharmaceuticals, LLC
Glenveigh Pharmaceuticals, LLC: Form D filings
Glenveigh Pharmaceuticals, LLC, a biotechnology company in Chattanooga, TN, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on May 14, 2012, reports $1.1 million sold of a $1.8 million offering to 1 investor.
Find out what Glenveigh Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 CHESTNUT STREET, SUITE 230, Chattanooga, TN, 37402
- Phone
- (423) 243-3460
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1535853
The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2012 | New notice | $1,750,000 | $1,100,000 | $650,000 | 1 | Apr 30, 2012 | sec.gov |
| Nov 29, 2011 | New notice | $2,500,000 | $250,000 | $2,250,000 | 1 | Nov 14, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles David Adair | Executive Officer, Director | |
| Mark David Hackett | Director | |
| Lizbeth David Kennedy-Thomas | Director | |
| Richard C Proctor, Jr. | Executive Officer, Director | |
| Richard R Becherer | Director | |
| Ken David Couch | Director | |
| William R Russell | Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of May 14, 2012 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Glenveigh Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.